Role of immunotherapy in management of 1L NSCLC with high PD-L1"Speaker: Prof. Filippo de Marinis

Objective
To enhance the knowledge and science in
the management of lung cancer and
thoracic malignancies
To discuss the recent updates in thoracic
malignancies management post ASCO
Target Audience
All oncology healthcare professionals from all
specialties (medical, surgical, radiation oncology,
pathology and radiology) and disciplines
(physicians, pharmacists and others)